000710 贝瑞基因
已收盘 12-19 15:00:00
资讯
新帖
简况
贝瑞基因：12月2日高管高扬减持股份合计92.67万股
证券之星 · 12-03
贝瑞基因：12月2日高管高扬减持股份合计92.67万股
贝瑞基因：控股股东高扬354万股将被强制变现
财中社 · 11-19
贝瑞基因：控股股东高扬354万股将被强制变现
贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%
证券之星 · 11-11
贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%
异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板
证券之星 · 11-03
异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板
股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%
证券之星 · 11-03
股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%
贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大
证券之星 · 11-01
贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大
贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证
证券之星 · 10-31
贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证
贝瑞基因(000710.SZ)发布前三季度业绩，归母净亏损5256.37万元
智通财经 · 10-31
贝瑞基因(000710.SZ)发布前三季度业绩，归母净亏损5256.37万元
贝瑞基因（000710）披露控股股东之一致行动人所持公司股份被司法拍卖的进展公告，10月13日股价下跌1.68%
证券之星 · 10-13
贝瑞基因（000710）披露控股股东之一致行动人所持公司股份被司法拍卖的进展公告，10月13日股价下跌1.68%
贝瑞基因（000710）披露控股股东之一致行动人所持公司股份将被司法拍卖的进展公告，9月18日股价下跌1.43%
证券之星 · 09-18
贝瑞基因（000710）披露控股股东之一致行动人所持公司股份将被司法拍卖的进展公告，9月18日股价下跌1.43%
贝瑞基因：9月3日高管高扬减持股份合计10.21万股
证券之星 · 09-04
贝瑞基因：9月3日高管高扬减持股份合计10.21万股
贝瑞基因：9月1日高管高扬减持股份合计239.85万股
证券之星 · 09-02
贝瑞基因：9月1日高管高扬减持股份合计239.85万股
股市必读：贝瑞基因中报 - 第二季度单季净利润同比下降2121.98%
证券之星 · 09-01
股市必读：贝瑞基因中报 - 第二季度单季净利润同比下降2121.98%
贝瑞基因（000710）2025年中报简析：净利润同比下降394.11%，公司应收账款体量较大
证券之星 · 08-31
贝瑞基因（000710）2025年中报简析：净利润同比下降394.11%，公司应收账款体量较大
图解贝瑞基因中报：第二季度单季净利润同比下降2121.98%
证券之星 · 08-30
图解贝瑞基因中报：第二季度单季净利润同比下降2121.98%
贝瑞基因：全资子公司基因测序仪NovaSeq™6000Dx-CN-BG获得医疗器械注册证
金融界 · 08-26
贝瑞基因：全资子公司基因测序仪NovaSeq™6000Dx-CN-BG获得医疗器械注册证
8月25日贝瑞基因涨5.19%，华富智慧城市灵活配置混合A基金重仓该股
证券之星 · 08-25
8月25日贝瑞基因涨5.19%，华富智慧城市灵活配置混合A基金重仓该股
贝瑞基因10.01%涨停，总市值61.41亿元
金融界 · 08-25
贝瑞基因10.01%涨停，总市值61.41亿元
异动快报：贝瑞基因（000710）8月22日13点2分触及涨停板
证券之星 · 08-22
异动快报：贝瑞基因（000710）8月22日13点2分触及涨停板
贝瑞基因子公司拟对外投资 推进新生儿及儿童基因病一体化检测服务
证券日报 · 08-10
贝瑞基因子公司拟对外投资 推进新生儿及儿童基因病一体化检测服务
公司概况
公司名称：
成都市贝瑞和康基因技术股份有限公司
所属行业：
专业技术服务业
上市日期：
1997-04-22
主营业务：
成都市贝瑞和康基因技术股份有限公司的主营业务是以高通量测序技术、三代HiFi测序技术为基础的基因检测服务和基因检测相关的设备、试剂、软件销售。公司的主要产品是覆盖出生缺陷三级预防的生育健康基因检测及覆盖儿童及成人的遗传病基因检测服务。
发行价格：
5.10
{"stockData":{"symbol":"000710","market":"SZ","secType":"STK","nameCN":"贝瑞基因","latestPrice":11.68,"timestamp":1766127804000,"preClose":11.75,"halted":0,"volume":10137172,"delay":0,"changeRate":-0.006,"floatShares":330000000,"shares":354000000,"eps":-0.7224,"marketStatus":"已收盘","change":-0.07,"latestTime":"12-19 15:00:00","open":11.77,"high":11.79,"low":11.49,"amount":118000000,"amplitude":0.0255,"askPrice":11.69,"askSize":82,"bidPrice":11.68,"bidSize":273,"shortable":0,"etf":0,"ttmEps":-0.7224,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.75,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":12.93,"lowLimit":10.58,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":353521465,"isCdr":false,"pbRate":2.56,"roa":"--","roe":"--","epsLYR":-0.5443,"committee":0.3553,"marketValue":4129000000,"turnoverRate":0.0308,"status":1,"floatMarketCap":3849000000},"requestUrl":"/m/hq/s/000710/wiki","defaultTab":"wiki","newsList":[{"id":"2588594049","title":"贝瑞基因：12月2日高管高扬减持股份合计92.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588594049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588594049?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:01","pubTimestamp":1764766906,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月3日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2025年12月2日公司董事,高管高扬共减持公司股份92.67万股，占公司总股本为0.2621%。变动期间公司股价下跌1.64%，12月2日当日收盘报11.96元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0102","000710","BK0081","BK0042","BK0221","BK0028","BK0139"],"gpt_icon":0},{"id":"2584794135","title":"贝瑞基因：控股股东高扬354万股将被强制变现","url":"https://stock-news.laohu8.com/highlight/detail?id=2584794135","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584794135?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:50","pubTimestamp":1763556600,"startTime":"0","endTime":"0","summary":"贝瑞基因发布公告，高扬因在国信证券开展的股票质押回购业务发生违约，成渝金融法院裁定强制变现其持有的354万股“贝瑞基因”股票，占公司总股本比例0.999%。 本次被执行股份的来源为高扬在公司进行重大资产重组时以持有的贝瑞和康股权认购获得的新增股份。被执行股份的交易将于2025年12月1日至2026年2月10日进行，交易价格将根据市场情况确定。 2025年前三季度，贝瑞基因实现收入6.86亿元，归母净利润-5256万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxxwtw3039155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0221","BK0086","BK0102","BK0081","BK0139","000710","BK0042","BK0028"],"gpt_icon":0},{"id":"2582620723","title":"贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582620723","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582620723?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:22","pubTimestamp":1762870944,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，贝瑞基因报收于13.53元，较前一交易日下跌0.95%，最新总市值为47.83亿元。公司董事会认为该反担保风险可控，不存在损害公司及股东利益的情形。截至公告日，公司及控股子公司对外担保总额为30,700万元，占最近一期经审计净资产的18.28%，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0081","BK0102","BK0042","BK0086","BK0221","000710","BK0139"],"gpt_icon":0},{"id":"2580255774","title":"异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580255774?lang=zh_cn&edition=full","pubTime":"2025-11-03 09:45","pubTimestamp":1762134324,"startTime":"0","endTime":"0","summary":"证券之星11月3日盘中消息，9点44分贝瑞基因触及涨停板。目前价格14.4，上涨10.01%。其所属行业医疗服务目前下跌。领涨股为百诚医药。该股为DeepSeek概念股，AI 医疗，人工智能概念热股，当日DeepSeek概念股概念上涨0.91%，AI 医疗概念上涨0.53%，人工智能概念上涨0.4%。10月31日的资金流向数据方面，主力资金净流出707.64万元，占总成交额4.08%，游资资金净流出884.27万元，占总成交额5.1%，散户资金净流入1591.91万元，占总成交额9.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300004949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0081","BK0028","BK0102","BK0221","BK0086","BK0042","BK0139"],"gpt_icon":0},{"id":"2580002239","title":"股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580002239","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580002239?lang=zh_cn&edition=full","pubTime":"2025-11-03 05:46","pubTimestamp":1762119976,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2025年9月30日，贝瑞基因股东户数为6.47万户，较6月30日减少3472.0户，减幅为5.09%。业绩披露要点财务报告贝瑞基因2025年三季报显示，前三季度主营收入6.86亿元，同比下降16.65%；归母净利润-5256.37万元，同比下降606.13%；扣非净利润-5379.14万元，同比下降519.85%。2025年第三季度单季度主营收入2.38亿元，同比下降12.06%；单季度归母净利润-2532.12万元，同比下降2355.45%；单季度扣非净利润-2520.19万元，同比下降858.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2580412210","title":"贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2580412210","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580412210?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:36","pubTimestamp":1761950170,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期贝瑞基因发布2025年三季报。截至本报告期末，公司营业总收入6.86亿元，同比下降16.65%，归母净利润-5256.37万元，同比下降606.13%。本报告期贝瑞基因公司应收账款体量较大，当期应收账款占最新年报营业总收入比达58.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2579345493","title":"贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2579345493","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579345493?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:53","pubTimestamp":1761904397,"startTime":"0","endTime":"0","summary":"贝瑞基因(000710.SZ)公告称，全资子公司杭州贝瑞和康基因诊断技术有限公司的三代基因测序仪SequelIICNDx近日获得国家药品监督管理局颁发的医疗器械注册证。三代基因测序仪Sequel II CNDx ，是全球首款获准应用于临床的三代基因测序平台。截至目前，贝瑞基因已完全实现三代测序配套检测试剂的自主生产和智能化解读报告系统的本地部署交付。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100038263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1222","BK0086","000710","BK1100","09996","09997","BK0081","159883","BK0102","BK0221","BK0139","BK1583","BK0028","BK0042"],"gpt_icon":0},{"id":"2579012780","title":"贝瑞基因(000710.SZ)发布前三季度业绩，归母净亏损5256.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579012780","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579012780?lang=zh_cn&edition=full","pubTime":"2025-10-31 00:41","pubTimestamp":1761842482,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝瑞基因(000710.SZ)发布2025年三季度报告，前三季度，公司实现营业收入6.86亿元，同比下降16.65%。归属于上市公司股东净亏损5256.37万元。归属于上市公司股东的扣除非经常性损益净亏损5379.14万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"贝瑞基因(000710.SZ)发布前三季度业绩，归母净亏损5256.37万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0081","BK0102","BK0042","BK0086","BK0221","000710","BK0139"],"gpt_icon":0},{"id":"2575423407","title":"贝瑞基因（000710）披露控股股东之一致行动人所持公司股份被司法拍卖的进展公告，10月13日股价下跌1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575423407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575423407?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:22","pubTimestamp":1760365348,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，贝瑞基因报收于12.91元，较前一交易日下跌1.68%，最新总市值为45.64亿元。该股当日开盘12.59元，最高13.02元，最低12.42元，成交额达9752.99万元，换手率为2.31%。近日，贝瑞基因发布关于控股股东之一致行动人所持公司股份被司法拍卖的进展公告。公告显示，本次拍卖标的为侯颖持有的公司400,000股无限售流通股，占其持股比例100.00%，占公司总股本0.11%，该股份已被全部质押和司法再冻结。截至公告日，侯颖累计被司法拍卖股份达19,805,661股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300025225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","000710","BK0028","BK0139","BK0042","BK0102","BK0081","BK0086"],"gpt_icon":0},{"id":"2568405969","title":"贝瑞基因（000710）披露控股股东之一致行动人所持公司股份将被司法拍卖的进展公告，9月18日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568405969","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568405969?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:24","pubTimestamp":1758205466,"startTime":"0","endTime":"0","summary":"近日，贝瑞基因发布关于控股股东之一致行动人所持公司股份将被司法拍卖的进展公告。公告称，本次拍卖标的为侯颖女士持有的公司400,000股股票，占其持股比例100.00%，占公司总股本0.11%，为无限售流通股，已全部质押并司法再冻结。拍卖原因系国信证券与侯颖股票质押式回购合同纠纷，依据仲裁裁决由成渝金融法院执行。截至目前，侯颖累计被司法拍卖19,805,661股公司股份。若拍卖完成，侯颖不再持股，其与高扬的一致行动关系自动终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800037478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0102","000710","BK0028","BK0081","BK0042","BK0086","BK0221"],"gpt_icon":0},{"id":"2564775263","title":"贝瑞基因：9月3日高管高扬减持股份合计10.21万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564775263","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564775263?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:02","pubTimestamp":1756990956,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月4日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2025年9月3日公司董事,高管高扬共减持公司股份10.21万股，占公司总股本为0.0289%。变动期间公司股价下跌4.26%，9月3日当日收盘报13.93元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400035894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0042","BK0102","BK0221","BK0086","BK0139","BK0081","BK0028"],"gpt_icon":0},{"id":"2564991800","title":"贝瑞基因：9月1日高管高扬减持股份合计239.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564991800","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564991800?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:02","pubTimestamp":1756818121,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月2日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2025年9月1日公司董事,高管高扬共减持公司股份239.85万股，占公司总股本为0.6785%。变动期间公司股价上涨0.6%，9月1日当日收盘报15.14元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200037833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0139","000710","BK0086","BK0028","BK0081","BK0042","BK0221"],"gpt_icon":0},{"id":"2564869470","title":"股市必读：贝瑞基因中报 - 第二季度单季净利润同比下降2121.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564869470","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564869470?lang=zh_cn&edition=full","pubTime":"2025-09-01 09:31","pubTimestamp":1756690316,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，贝瑞基因报收于15.05元，下跌1.51%，换手率6.95%，成交量22.72万手，成交额3.43亿元。来自股本股东变化：截至2025年6月30日，贝瑞基因股东户数为6.82万户，较3月31日增加6.86%。来自业绩披露要点：贝瑞基因2025年中报归母净利润为-2724.25万元，同比下降394.11%。股本股东变化股东户数变动截至2025年6月30日，贝瑞基因股东户数为6.82万户，较3月31日增加4375.0户，增幅6.86%；户均持股数量由上期的5540.0股下降至5185.0股，户均持股市值为7.02万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100002986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2563802288","title":"贝瑞基因（000710）2025年中报简析：净利润同比下降394.11%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2563802288","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563802288?lang=zh_cn&edition=full","pubTime":"2025-08-31 06:22","pubTimestamp":1756592560,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期贝瑞基因发布2025年中报。截至本报告期末，公司营业总收入4.47亿元，同比下降18.91%，归母净利润-2724.25万元，同比下降394.11%。本报告期贝瑞基因公司应收账款体量较大，当期应收账款占最新年报营业总收入比达61.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100001809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2563270075","title":"图解贝瑞基因中报：第二季度单季净利润同比下降2121.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563270075","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563270075?lang=zh_cn&edition=full","pubTime":"2025-08-30 01:51","pubTimestamp":1756489908,"startTime":"0","endTime":"0","summary":"证券之星消息，贝瑞基因2025年中报显示，公司主营收入4.47亿元，同比下降18.91%；归母净利润-2724.25万元，同比下降394.11%；扣非净利润-2858.95万元，同比下降401.26%；其中2025年第二季度，公司单季度主营收入2.3亿元，同比下降15.65%；单季度归母净利润-2078.03万元，同比下降2121.98%；单季度扣非净利润-2490.68万元，同比下降4882.11%；负债率30.6%，投资收益325.76万元，财务费用328.54万元，毛利率49.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000004887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2562804957","title":"贝瑞基因：全资子公司基因测序仪NovaSeq™6000Dx-CN-BG获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2562804957","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562804957?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:58","pubTimestamp":1756205908,"startTime":"0","endTime":"0","summary":"贝瑞基因(000710.SZ)公告称，公司全资子公司杭州贝瑞和康基因诊断技术有限公司的NovaSeq™6000Dx-CN-BG基因测序仪近日获得国家药品监督管理局颁发的医疗器械注册证。该产品采用可逆末端终止测序技术，在临床上用于人脱氧核糖核酸（DNA）测序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/26185852708023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BG","BK0102","BK0081","LU0471298777.SGD","LU2360106947.USD","BK4588","BK1583","09997","BK0221","BK4189","LU0471298694.HKD","CN","BK0042","BK1574","LU0048573561.USD","BK0086","BK1222","LU0251131958.USD","LU0385154629.USD","LU2211817866.USD","000710","BK0028","LU0742534661.SGD","09996","159883","BK0139","LU0251142724.SGD","BK4585","BK1100"],"gpt_icon":0},{"id":"2562321147","title":"8月25日贝瑞基因涨5.19%，华富智慧城市灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562321147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562321147?lang=zh_cn&edition=full","pubTime":"2025-08-25 16:28","pubTimestamp":1756110505,"startTime":"0","endTime":"0","summary":"证券之星消息，8月25日贝瑞基因涨5.19%创60日新高，收盘报16.61元，换手率32.36%，成交量105.78万手，成交额17.31亿元。重仓贝瑞基因的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华富基金的华富智慧城市灵活配置混合A。华富智慧城市灵活配置混合A目前规模为0.24亿元，最新净值1.0713，较上一交易日上涨3.77%，近一年上涨36.38%。该公募基金现任基金经理为黄星霖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500021743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0221","BK0081","BK0102","BK0042","BK0139","BK0028","BK0086"],"gpt_icon":0},{"id":"2562290561","title":"贝瑞基因10.01%涨停，总市值61.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562290561","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562290561?lang=zh_cn&edition=full","pubTime":"2025-08-25 13:06","pubTimestamp":1756098391,"startTime":"0","endTime":"0","summary":"8月25日，贝瑞基因盘中10.01%涨停，截至13:06，报17.37元/股，成交13.02亿元，换手率24.64%，总市值61.41亿元。截至3月31日，贝瑞基因股东户数6.38万，人均流通股5122股。2025年1月-3月，贝瑞基因实现营业收入2.18亿元，同比减少22.08%；归属净利润-646.22万元，同比减少178.47%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/25130652662954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0102","000710","BK0042","BK0028","BK0221","BK0081","BK0139","BK0086"],"gpt_icon":0},{"id":"2561501440","title":"异动快报：贝瑞基因（000710）8月22日13点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2561501440","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561501440?lang=zh_cn&edition=full","pubTime":"2025-08-22 13:05","pubTimestamp":1755839130,"startTime":"0","endTime":"0","summary":"证券之星8月22日盘中消息，13点2分贝瑞基因触及涨停板。目前价格15.79，上涨10.03%。其所属行业医疗服务目前下跌。领涨股为皓宸医疗。该股为DeepSeek概念股，人工智能，AI医疗概念热股，当日DeepSeek概念股概念上涨3.0%，人工智能概念上涨1.21%，AI医疗概念上涨0.99%。8月22日的资金流向数据方面，主力资金净流入7483.2万元，占总成交额19.27%，游资资金净流出561.24万元，占总成交额1.45%，散户资金净流出6921.97万元，占总成交额17.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200020134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0086","BK0042","BK0028","BK0221","BK0081","BK0102","000710"],"gpt_icon":0},{"id":"2558681689","title":"贝瑞基因子公司拟对外投资 推进新生儿及儿童基因病一体化检测服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681689","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681689?lang=zh_cn&edition=full","pubTime":"2025-08-10 21:39","pubTimestamp":1754833140,"startTime":"0","endTime":"0","summary":" 据悉，为更好地推动新生儿及儿童基因病一体化检测服务体系建设，贝瑞和康拟同李巍投资设立合资公司，计划以公共医疗机构和临床医疗企业紧密合作的形式，在河南等重点区域开展新生儿及儿童基因病一体化检测服务。 资料显示，贝瑞基因长期以来深耕产科、儿科和遗传科领域，专注于以基因测序为基础的临床检测服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-10/doc-infkpkpp1106113.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-10/doc-infkpkpp1106113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0086","BK0028","BK0102","BK0081","BK0221","BK0042","BK0139","000710"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766157837062,"stockEarnings":[{"period":"1week","weight":0.0586},{"period":"1month","weight":-0.1565},{"period":"3month","weight":-0.1105},{"period":"6month","weight":-0.0697},{"period":"1year","weight":0.119},{"period":"ytd","weight":0.3905}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都市贝瑞和康基因技术股份有限公司","boardCode":"AI0074","boardName":"专业技术服务业","stockholders":"64711人(较上一季度减少5.09%)","perCapita":"5092股","listingDate":"1997-04-22","address":"四川省成都市龙泉驿区经济技术开发区(龙泉驿区)成都汽车城大道333号","registeredCapital":"35352万元","survey":" 成都市贝瑞和康基因技术股份有限公司的主营业务是以高通量测序技术、三代HiFi测序技术为基础的基因检测服务和基因检测相关的设备、试剂、软件销售。公司的主要产品是覆盖出生缺陷三级预防的生育健康基因检测及覆盖儿童及成人的遗传病基因检测服务。","listedPrice":5.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝瑞基因,000710,贝瑞基因股票,贝瑞基因股票老虎,贝瑞基因股票老虎国际,贝瑞基因行情,贝瑞基因股票行情,贝瑞基因股价,贝瑞基因股市,贝瑞基因股票价格,贝瑞基因股票交易,贝瑞基因股票购买,贝瑞基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}